The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients

Tetsu Akimoto, Kazuhiro Shiizaki, Taro Sugase, Yuko Watanabe, Hiromichi Yoshizawa, Naoko Otani, Akihiko Numata, Eri Takeshima, Tomoyuki Yamazaki, Takuya Miki, Chiharu Ito, Johanne V. Pastor, Yoshitaka Iwazu, Osamu Saito, Shigeaki Muto, Makoto Kuro-O, Eiji Kusano

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background Klotho has been investigated as an antiaging protein that is predominantly expressed in the distal convoluted tubules in the kidneys and in the choroid plexus of the brain. The purpose of the present study was to determine the relationship between the soluble form of Klotho and renal function in chronic peritoneal dialysis (PD) patients, a relationship which remains poorly understood. Methods The soluble Klotho levels in the serum, urine, and peritoneal dialysate obtained from thirty-six PD patients were determined by a sandwich enzyme-linked immunosorbent assay system. Results The amount of urinary excreted soluble Klotho over 24 h ranged from 1.54 to 1774.4 ng/day (median 303.2 ng/day; interquartile range [IR] 84.1-498.5), while the serum soluble Klotho concentration ranged from 194.4 to 990.4 pg/ml (mean 553.7 ± 210.4 pg/ml). The amount of urinary Klotho excretion was significantly correlated with residual renal function. However, there was no apparent correlation between the serum soluble Klotho levels and the residual renal function. Klotho was also detected in the 24-h dialysate collections. There was a significant correlation between the peritoneal Klotho excretion and the amount of albumin contained in the dialysate collections (r = 0.798, P<0.01). Conclusions The total amount of urinary excreted Klotho, but not the serum level of soluble Klotho, may be a potential biomarker for assessing the residual renal function among PD patients. Whether our findings are also valid for chronic kidney disease patients overall should therefore be evaluated in greater detail.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalClinical and Experimental Nephrology
Volume16
Issue number3
DOIs
StatePublished - Jun 2012

Fingerprint

Peritoneal Dialysis
Dialysis Solutions
Kidney
Serum
Kidney Tubules
Choroid Plexus
Chronic Renal Insufficiency
Albumins
Biomarkers
Enzyme-Linked Immunosorbent Assay
Urine
klotho protein
Brain
Proteins

Keywords

  • Chronic kidney disease
  • ELISA
  • Klotho
  • Peritoneal dialysis
  • Residual renal function

ASJC Scopus subject areas

  • Nephrology
  • Physiology
  • Physiology (medical)

Cite this

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. / Akimoto, Tetsu; Shiizaki, Kazuhiro; Sugase, Taro; Watanabe, Yuko; Yoshizawa, Hiromichi; Otani, Naoko; Numata, Akihiko; Takeshima, Eri; Yamazaki, Tomoyuki; Miki, Takuya; Ito, Chiharu; Pastor, Johanne V.; Iwazu, Yoshitaka; Saito, Osamu; Muto, Shigeaki; Kuro-O, Makoto; Kusano, Eiji.

In: Clinical and Experimental Nephrology, Vol. 16, No. 3, 06.2012, p. 442-447.

Research output: Contribution to journalArticle

Akimoto, T, Shiizaki, K, Sugase, T, Watanabe, Y, Yoshizawa, H, Otani, N, Numata, A, Takeshima, E, Yamazaki, T, Miki, T, Ito, C, Pastor, JV, Iwazu, Y, Saito, O, Muto, S, Kuro-O, M & Kusano, E 2012, 'The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients', Clinical and Experimental Nephrology, vol. 16, no. 3, pp. 442-447. https://doi.org/10.1007/s10157-011-0582-2
Akimoto, Tetsu ; Shiizaki, Kazuhiro ; Sugase, Taro ; Watanabe, Yuko ; Yoshizawa, Hiromichi ; Otani, Naoko ; Numata, Akihiko ; Takeshima, Eri ; Yamazaki, Tomoyuki ; Miki, Takuya ; Ito, Chiharu ; Pastor, Johanne V. ; Iwazu, Yoshitaka ; Saito, Osamu ; Muto, Shigeaki ; Kuro-O, Makoto ; Kusano, Eiji. / The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. In: Clinical and Experimental Nephrology. 2012 ; Vol. 16, No. 3. pp. 442-447.
@article{64bd3767d2c94db09ac5a05d1f3669e3,
title = "The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients",
abstract = "Background Klotho has been investigated as an antiaging protein that is predominantly expressed in the distal convoluted tubules in the kidneys and in the choroid plexus of the brain. The purpose of the present study was to determine the relationship between the soluble form of Klotho and renal function in chronic peritoneal dialysis (PD) patients, a relationship which remains poorly understood. Methods The soluble Klotho levels in the serum, urine, and peritoneal dialysate obtained from thirty-six PD patients were determined by a sandwich enzyme-linked immunosorbent assay system. Results The amount of urinary excreted soluble Klotho over 24 h ranged from 1.54 to 1774.4 ng/day (median 303.2 ng/day; interquartile range [IR] 84.1-498.5), while the serum soluble Klotho concentration ranged from 194.4 to 990.4 pg/ml (mean 553.7 ± 210.4 pg/ml). The amount of urinary Klotho excretion was significantly correlated with residual renal function. However, there was no apparent correlation between the serum soluble Klotho levels and the residual renal function. Klotho was also detected in the 24-h dialysate collections. There was a significant correlation between the peritoneal Klotho excretion and the amount of albumin contained in the dialysate collections (r = 0.798, P<0.01). Conclusions The total amount of urinary excreted Klotho, but not the serum level of soluble Klotho, may be a potential biomarker for assessing the residual renal function among PD patients. Whether our findings are also valid for chronic kidney disease patients overall should therefore be evaluated in greater detail.",
keywords = "Chronic kidney disease, ELISA, Klotho, Peritoneal dialysis, Residual renal function",
author = "Tetsu Akimoto and Kazuhiro Shiizaki and Taro Sugase and Yuko Watanabe and Hiromichi Yoshizawa and Naoko Otani and Akihiko Numata and Eri Takeshima and Tomoyuki Yamazaki and Takuya Miki and Chiharu Ito and Pastor, {Johanne V.} and Yoshitaka Iwazu and Osamu Saito and Shigeaki Muto and Makoto Kuro-O and Eiji Kusano",
year = "2012",
month = "6",
doi = "10.1007/s10157-011-0582-2",
language = "English (US)",
volume = "16",
pages = "442--447",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients

AU - Akimoto, Tetsu

AU - Shiizaki, Kazuhiro

AU - Sugase, Taro

AU - Watanabe, Yuko

AU - Yoshizawa, Hiromichi

AU - Otani, Naoko

AU - Numata, Akihiko

AU - Takeshima, Eri

AU - Yamazaki, Tomoyuki

AU - Miki, Takuya

AU - Ito, Chiharu

AU - Pastor, Johanne V.

AU - Iwazu, Yoshitaka

AU - Saito, Osamu

AU - Muto, Shigeaki

AU - Kuro-O, Makoto

AU - Kusano, Eiji

PY - 2012/6

Y1 - 2012/6

N2 - Background Klotho has been investigated as an antiaging protein that is predominantly expressed in the distal convoluted tubules in the kidneys and in the choroid plexus of the brain. The purpose of the present study was to determine the relationship between the soluble form of Klotho and renal function in chronic peritoneal dialysis (PD) patients, a relationship which remains poorly understood. Methods The soluble Klotho levels in the serum, urine, and peritoneal dialysate obtained from thirty-six PD patients were determined by a sandwich enzyme-linked immunosorbent assay system. Results The amount of urinary excreted soluble Klotho over 24 h ranged from 1.54 to 1774.4 ng/day (median 303.2 ng/day; interquartile range [IR] 84.1-498.5), while the serum soluble Klotho concentration ranged from 194.4 to 990.4 pg/ml (mean 553.7 ± 210.4 pg/ml). The amount of urinary Klotho excretion was significantly correlated with residual renal function. However, there was no apparent correlation between the serum soluble Klotho levels and the residual renal function. Klotho was also detected in the 24-h dialysate collections. There was a significant correlation between the peritoneal Klotho excretion and the amount of albumin contained in the dialysate collections (r = 0.798, P<0.01). Conclusions The total amount of urinary excreted Klotho, but not the serum level of soluble Klotho, may be a potential biomarker for assessing the residual renal function among PD patients. Whether our findings are also valid for chronic kidney disease patients overall should therefore be evaluated in greater detail.

AB - Background Klotho has been investigated as an antiaging protein that is predominantly expressed in the distal convoluted tubules in the kidneys and in the choroid plexus of the brain. The purpose of the present study was to determine the relationship between the soluble form of Klotho and renal function in chronic peritoneal dialysis (PD) patients, a relationship which remains poorly understood. Methods The soluble Klotho levels in the serum, urine, and peritoneal dialysate obtained from thirty-six PD patients were determined by a sandwich enzyme-linked immunosorbent assay system. Results The amount of urinary excreted soluble Klotho over 24 h ranged from 1.54 to 1774.4 ng/day (median 303.2 ng/day; interquartile range [IR] 84.1-498.5), while the serum soluble Klotho concentration ranged from 194.4 to 990.4 pg/ml (mean 553.7 ± 210.4 pg/ml). The amount of urinary Klotho excretion was significantly correlated with residual renal function. However, there was no apparent correlation between the serum soluble Klotho levels and the residual renal function. Klotho was also detected in the 24-h dialysate collections. There was a significant correlation between the peritoneal Klotho excretion and the amount of albumin contained in the dialysate collections (r = 0.798, P<0.01). Conclusions The total amount of urinary excreted Klotho, but not the serum level of soluble Klotho, may be a potential biomarker for assessing the residual renal function among PD patients. Whether our findings are also valid for chronic kidney disease patients overall should therefore be evaluated in greater detail.

KW - Chronic kidney disease

KW - ELISA

KW - Klotho

KW - Peritoneal dialysis

KW - Residual renal function

UR - http://www.scopus.com/inward/record.url?scp=84863720655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863720655&partnerID=8YFLogxK

U2 - 10.1007/s10157-011-0582-2

DO - 10.1007/s10157-011-0582-2

M3 - Article

C2 - 22350461

AN - SCOPUS:84863720655

VL - 16

SP - 442

EP - 447

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 3

ER -